The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Jul. 27, 2012
Applicants:

Harold David Gunn, Vancouver, CA;

Salim Dhanji, North Vancouver, CA;

Brett Anthony Premack, San Francisco, CA (US);

Michael Tak Huai Chow, Richmond, CA;

Inventors:

Harold David Gunn, Vancouver, CA;

Salim Dhanji, North Vancouver, CA;

Brett Anthony Premack, San Francisco, CA (US);

Michael Tak Huai Chow, Richmond, CA;

Assignee:

Qu Biologics, Vancouver, CA;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/108 (2006.01); A61K 39/00 (2006.01); A61K 39/112 (2006.01); A61K 39/085 (2006.01); A61K 39/09 (2006.01); A61K 39/05 (2006.01); A61K 39/095 (2006.01); A61K 39/102 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0258 (2013.01); A61K 39/0008 (2013.01); A61K 39/0011 (2013.01); A61K 39/0266 (2013.01); A61K 39/0275 (2013.01); A61K 39/085 (2013.01); A61K 39/092 (2013.01); A61K 2039/521 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/58 (2013.01); A61K 2039/585 (2013.01); A61K 39/05 (2013.01); A61K 39/095 (2013.01); A61K 39/102 (2013.01); A61K 2039/542 (2013.01); A61K 2039/70 (2013.01); Y10S 514/867 (2013.01);
Abstract

The invention provides methods of treating inflammation in a specific organ or tissue of an individual. The method involves determining whether the individual has previously been infected with at least one pathogen that is pathogenic in the specific organ or tissue; and administering to the individual an anti-inflammatory composition comprising antigenic determinants, the antigenic determinants selected or formulated so that together they are specific for the at least one pathogen. The pathogen may be an endogenous or exogenous pathogen, and may further be a bacterial pathogen, a viral pathogen, a fungal pathogen, a protozoan pathogen, or a helminth pathogen.


Find Patent Forward Citations

Loading…